Neurocrine Biosciences stock is in a buy zone while Tandem Diabetes stock is just below a potential entry. Bristol Myers stock, Teladoc stock and Quidel stock are in various stages of consolidation. All of these health care stocks are worth considering for your watchlist. It is wise for investors to keep tabs on a number of strong stocks, even when in cash, to be ready to pull the trigger when breakouts occur among promising names.
The weekend is an excellent time to update your watchlist, as you can study the market and weekly charts without the distraction of intraday fluctuations.
Neurocrine Biosciences Stock
Neurocrine Biosciences stock